The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma.
Saved in:
| Title: | The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. |
|---|---|
| Authors: | Pawlyn C; The Institute of Cancer Research, London, United Kingdom., Kaiser MF; The Institute of Cancer Research, London, United Kingdom., Heuck C; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Melchor L; The Institute of Cancer Research, London, United Kingdom., Wardell CP; The Institute of Cancer Research, London, United Kingdom., Murison A; The Institute of Cancer Research, London, United Kingdom., Chavan SS; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Johnson DC; The Institute of Cancer Research, London, United Kingdom., Begum DB; The Institute of Cancer Research, London, United Kingdom., Dahir NM; The Institute of Cancer Research, London, United Kingdom., Proszek PZ; The Institute of Cancer Research, London, United Kingdom., Cairns DA; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Boyle EM; The Institute of Cancer Research, London, United Kingdom., Jones JR; The Institute of Cancer Research, London, United Kingdom., Cook G; University of Leeds, Leeds, United Kingdom., Drayson MT; Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom., Owen RG; St James's University Hospital, Leeds, United Kingdom., Gregory WM; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom., Jackson GH; Department of Haematology, Newcastle University, Newcastle, United Kingdom., Barlogie B; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Davies FE; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Walker BA; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas., Morgan GJ; The Institute of Cancer Research, London, United Kingdom. GJMorgan@uams.edu.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas. |
| Source: | Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Dec 01; Vol. 22 (23), pp. 5783-5794. Date of Electronic Publication: 2016 May 27. |
| Publication Type: | Clinical Trial; Journal Article |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 27235425 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kaiser+MF%22">Kaiser MF</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Heuck+C%22">Heuck C</searchLink>; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Melchor+L%22">Melchor L</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wardell+CP%22">Wardell CP</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Murison+A%22">Murison A</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chavan+SS%22">Chavan SS</searchLink>; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Johnson+DC%22">Johnson DC</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Begum+DB%22">Begum DB</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Dahir+NM%22">Dahir NM</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Proszek+PZ%22">Proszek PZ</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cairns+DA%22">Cairns DA</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Boyle+EM%22">Boyle EM</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jones+JR%22">Jones JR</searchLink>; The Institute of Cancer Research, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cook+G%22">Cook G</searchLink>; University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Drayson+MT%22">Drayson MT</searchLink>; Clinical Immunology, School of Immunity and Infection, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Owen+RG%22">Owen RG</searchLink>; St James's University Hospital, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Gregory+WM%22">Gregory WM</searchLink>; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jackson+GH%22">Jackson GH</searchLink>; Department of Haematology, Newcastle University, Newcastle, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Barlogie+B%22">Barlogie B</searchLink>; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Davies+FE%22">Davies FE</searchLink>; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Walker+BA%22">Walker BA</searchLink>; The Institute of Cancer Research, London, United Kingdom.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas.<br /><searchLink fieldCode="AU" term="%22Morgan+GJ%22">Morgan GJ</searchLink>; The Institute of Cancer Research, London, United Kingdom. GJMorgan@uams.edu.; Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229502500%22">Clinical cancer research : an official journal of the American Association for Cancer Research</searchLink> [Clin Cancer Res] 2016 Dec 01; Vol. 22 (23), pp. 5783-5794. <i>Date of Electronic Publication: </i>2016 May 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502500 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1557-3265 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210780432%22">10780432 </searchLink><i>NLM ISO Abbreviation: </i>Clin Cancer Res <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=27235425 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1158/1078-0432.CCR-15-1790 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 5783 Titles: – TitleFull: The Spectrum and Clinical Impact of Epigenetic Modifier Mutations in Myeloma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Pawlyn C – PersonEntity: Name: NameFull: Kaiser MF – PersonEntity: Name: NameFull: Heuck C – PersonEntity: Name: NameFull: Melchor L – PersonEntity: Name: NameFull: Wardell CP – PersonEntity: Name: NameFull: Murison A – PersonEntity: Name: NameFull: Chavan SS – PersonEntity: Name: NameFull: Johnson DC – PersonEntity: Name: NameFull: Begum DB – PersonEntity: Name: NameFull: Dahir NM – PersonEntity: Name: NameFull: Proszek PZ – PersonEntity: Name: NameFull: Cairns DA – PersonEntity: Name: NameFull: Boyle EM – PersonEntity: Name: NameFull: Jones JR – PersonEntity: Name: NameFull: Cook G – PersonEntity: Name: NameFull: Drayson MT – PersonEntity: Name: NameFull: Owen RG – PersonEntity: Name: NameFull: Gregory WM – PersonEntity: Name: NameFull: Jackson GH – PersonEntity: Name: NameFull: Barlogie B – PersonEntity: Name: NameFull: Davies FE – PersonEntity: Name: NameFull: Walker BA – PersonEntity: Name: NameFull: Morgan GJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Text: 2016 Dec 01 Type: published Y: 2016 Identifiers: – Type: issn-electronic Value: 1557-3265 Numbering: – Type: volume Value: 22 – Type: issue Value: 23 Titles: – TitleFull: Clinical cancer research : an official journal of the American Association for Cancer Research Type: main |
| ResultId | 1 |